Fosavance · DIN 02276429 · 70 mg & 70 mcg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Savings card: RxHelp ONE lists Fosavance (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Fosavance · DIN 02276429
Manufacturer: Organon Canada Inc.; listing date 2007-01-02
Health Canada: Marketed since 2022-06-29 · brand FOSAVANCE · ATC M05BB03 ALENDRONIC ACID AND CHOLECALCIFEROL · form Tablet · route Oral · ingredients ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG, VITAMIN D3 (VITAMIN D3) 2800 UNIT · company Organon canada inc. · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02276429)
Source record
DIN 02276429: Fosavance
Raw flags: chronicUseMed=Y, sec3=Y
Item: 920000544; group id 892; item number 2143; lccId None; manufacturer id OCI
Source form: Tab; strength: 70mg & 70mcg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $5.5335; ministry $2.4348
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02276429
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76210
Therapeutic Notes (formulary)
Note: The recommended dose of Vitamin D for osteoporosis prevention and treatment in adults over 50 years old is at least 800 IU/day, in conjunction with calcium. This product does not provide the total recommended daily intake of Vitamin D; supplemental Vitamin D may be required. The appropriate dosage of ALENDRONATE & CHOLECALCIFEROL must be determined by the physician based on the patient's vitamin D requirement.
Interchangeable products
Apo-Alendronate/Vitamin D3 · DIN 02454467 · $2.4348
Jamp Alendronate/Vitamin D3 · DIN 02519828 · $2.4348
Shortage status: not checked (no credentials)